Van Buchem disease is a dubious disease in the field of genetic metabolism, clinical performance is complex and often involves multi-systematic stress. Early identification and standardised clinical care are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
A platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment. Individualised development of treatment plans for treatment and management of van Buchem disease usually includes drug therapy, rehabilitation interventions, regular follow-up management, etc. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat genetic metabolic diseases have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule of disease changes. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of van Buchem disease. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.